Class Of Health Plans Certified In Avandia Marketing MDL

By P.J. D'Annunzio · May 23, 2025, 4:43 PM EDT

A Pennsylvania federal judge has certified a class of health plans in multidistrict litigation over GlaxoSmithKline's alleged deceptive marketing of the drug Avandia in which the plans claim they wouldn't have...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Decision

Case Information

Case Title

IN RE: AVANDIA MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION

Case Number

Court

Pennsylvania Eastern

Nature of Suit

P.I.: Personal Inj. Prod. Liability

Date Filed

October 18, 2007

Recent Articles By P.J.

May 14, 2025
Health Co. Founder Pleads Guilty In $5M Fraud Case
May 06, 2025
How A Small Pa. Firm Defended A Huge Fraud Case
April 25, 2025
Refusing Mental Healthcare Means Liability, Pa. Justices Rule
April 23, 2025
Genetic Testing Co., Marketer Settle FCA Case For $6M
April 17, 2025
3rd Circ. Questions Walmart's Duty To Disclose Opioid Probe
April 09, 2025
Religious Mission Justifies Philly Injection Site, 3rd Circ. Told
March 10, 2025
CVS PBM Caused Up To $330M In Part D Damages, Judge Told
March 03, 2025
Oddities Shop Owner Says Collecting Body Parts Not Criminal
February 27, 2025
CVS Freed From Hospital's Suit Over Drug Pricing Program
February 05, 2025
Penn Hospital Says $200M Judgment Imperils Local Care